Legal Representation
Attorney
REBECCA L WILSON
USPTO Deadlines
Application History
43 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Oct 5, 2024 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Apr 22, 2022 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Dec 12, 2021 | FINT | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
Nov 23, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
Nov 23, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
Nov 23, 2020 | MAB3 | E | ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL | Loading... |
Nov 19, 2020 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
Nov 19, 2020 | ABN3 | O | ABANDONMENT - AFTER EX PARTE APPEAL | Loading... |
Aug 25, 2020 | EXPA | T | EX PARTE APPEAL-REFUSAL AFFIRMED | Loading... |
May 23, 2020 | RBFT | T | REPLY BRIEF FILED - CHECK TTAB FILES | Loading... |
Apr 28, 2020 | GNSN | O | NOTIFICATION OF EXAMINERS STATEMENT E-MAILED | Loading... |
Apr 28, 2020 | GNES | O | EXAMINERS STATEMENT E-MAILED | Loading... |
Apr 28, 2020 | CNES | R | EXAMINERS STATEMENT - COMPLETED | Loading... |
Apr 17, 2020 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
Apr 1, 2020 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
Apr 1, 2020 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
Mar 13, 2020 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Jan 6, 2020 | GEA1 | O | NOTIFICATION OF ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
Jan 6, 2020 | GECD | O | ACTION DENYING REQ FOR RECON E-MAILED | Loading... |
Jan 6, 2020 | CNCF | S | ACTION CONTINUING FINAL - COMPLETED | Loading... |
Dec 27, 2019 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Dec 26, 2019 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
Dec 26, 2019 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
Dec 26, 2019 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
Dec 26, 2019 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
Jul 25, 2019 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
Jun 25, 2019 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
Jun 25, 2019 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
Jun 25, 2019 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
Jun 4, 2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
Jun 3, 2019 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jun 3, 2019 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
Jun 3, 2019 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
Jun 3, 2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
Dec 21, 2018 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
Dec 1, 2018 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
Dec 1, 2018 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
Nov 15, 2018 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
Nov 14, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 13, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Nov 7, 2018 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 7, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 1, 2018 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 005
Caloric substitutes for carbohydrates in the nature of nutritional supplements used to maintain, promote and enhance health, wellness and fitness and to treat medical conditions, namely, alzheimer's disease, parkinson's disease, depression, muscular conditions, treating, preventing or aiding recovery from fatigue, improving muscle function efficiency and muscular power, maintaining and improving cognitive function, raising blood ketone levels in the human or animal body, diabetes or disorder of glucose metabolism, cachexia, neuro-degenerative conditions, muscular dystrophic states, increasing metabolic efficiency, reducing fatigue, reducing muscle damage or wasting, inflammatory diseases and radiation damage, as well as epilepsy, anxiety, dementia, cancer, and cell damage; substances in the nature of nutritional and dietary supplements for the treatment of muscle fatigue, muscle conditions, epilepsy, anxiety, dementia, cancer, cachexia and cell damage and substances for improving cognitive function and raising ketone blood levels in humans or animals; all the aforementioned containing ketone esters or hydroxybutyrates as an integrated component ingredient
Additional Information
Design Mark
The mark consists of a thick-bordered Greek blue delta symbol with the term "delta" in stylized lowercase font appearing within the bottom edge. To the right of the symbol appears a large stylized blue letter "G." The color white appearing in the mark represents background or transparent areas only and is not claimed as a feature of the mark.
Color Claim
The color(s) blue is/are claimed as a feature of the mark.
Other
The transliteration of the non-Latin characters in the mark is: delta.
Classification
International Classes
005